| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 9216632 | Oral Oncology | 2005 | 6 Pages | 
Abstract
												The combination of radiotherapy and chemotherapy significantly decreases plasma TGF-β1 level in patients with advanced head and neck cancer. Treatment response cannot be predicted using TGF-β1.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Dentistry, Oral Surgery and Medicine
												
											Authors
												David Feltl, Eva Zavadova, Miloslav Pala, Pavel Hozak, 
											